Zomedica Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ZOM and buy or sell other stocks, ETFs, and their options commission-free!About ZOM
Zomedica Corp. engages in the discovery, development, and commercialization of pharmaceuticals for companion animals, including dogs, cats, and horses. It offers products focusing on the unmet needs of clinical veterinarians.
CEOLarry C. Heaton, II
CEOLarry C. Heaton, II
Employees152
Employees152
HeadquartersAnn Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded2013
Founded2013
Employees152
Employees152
ZOM Key Statistics
Market cap759.66M
Market cap759.66M
Price-Earnings ratio-1.79
Price-Earnings ratio-1.79
Dividend yield—
Dividend yield—
Average volume2.91M
Average volume2.91M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.1579
52 Week high$0.1579
52 Week low$0.0151
52 Week low$0.0151
Stock Snapshot
With a market cap of 759.66M, Zomedica Pharmaceuticals(ZOM) trades at $0.78. The stock has a price-to-earnings ratio of -1.79.
Zomedica Pharmaceuticals(ZOM) stock opened on 2026-01-14 at —. The price climbed to — and dipped to —.
The Zomedica Pharmaceuticals(ZOM)'s current trading volume is 0, compared to an average daily volume of 2.91M.
In the last year, Zomedica Pharmaceuticals(ZOM) shares hit a 52-week high of $0.16 and a 52-week low of $0.02.
In the last year, Zomedica Pharmaceuticals(ZOM) shares hit a 52-week high of $0.16 and a 52-week low of $0.02.
People also own
Based on the portfolios of people who own ZOM. This list is generated using Robinhood data, and it’s not a recommendation.